These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23559127)

  • 61. Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.
    Malmström PU; Grabe M; Haug ES; Hellström P; Hermann GG; Mogensen K; Raitanen M; Wahlqvist R
    Scand J Urol Nephrol; 2012 Apr; 46(2):108-16. PubMed ID: 22087730
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Developments in the follow-up of nonmuscle invasive bladder cancer: what did we learn in the last 24 months: a critical review.
    Witjes JA
    Curr Opin Urol; 2020 May; 30(3):387-391. PubMed ID: 32141938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Biopsy at flexible cystoscopy: is it worthwhile?
    Khan J; Kamal MS; D'Arcy FT; Dowling C
    Ir J Med Sci; 2021 Feb; 190(1):437-439. PubMed ID: 32613562
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years?
    Holmäng S; Ströck V
    Eur Urol; 2012 Mar; 61(3):503-7. PubMed ID: 22119022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New imaging techniques for non-muscle invasive bladder cancer: ready for primetime.
    Gillespie JA; O'Donnell MA
    Urol Clin North Am; 2013 May; 40(2):271-9. PubMed ID: 23540784
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical pitfalls in diagnosis of nonmuscle-invasive bladder cancer.
    Serretta V; Scalici Gesolfo C
    Urologia; 2015 Oct; 82 Suppl 2():S1-4. PubMed ID: 26481718
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimal intervals for follow-up cystoscopy in non-muscle invasive bladder cancer: a systematic review regarding oncological safety.
    Dreyer T; Ernst A; Jensen JB
    Scand J Urol; 2022 Feb; 56(1):39-46. PubMed ID: 34913840
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?
    Wong KA; Zisengwe G; Athanasiou T; O'Brien T; Thomas K
    BJU Int; 2013 Sep; 112(5):561-7. PubMed ID: 23819486
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The awareness of patients with non - muscle invasive bladder cancer regarding the importance of smoking cessation and their access to smoking cessation programs.
    Yuruk E; Tuken M; Colakerol A; Serefoglu EC
    Int Braz J Urol; 2017; 43(4):607-614. PubMed ID: 28537702
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration.
    Al Hussein Al Awamlh B; Lee R; Chughtai B; Donat SM; Sandhu JS; Herr HW
    Urology; 2015 Feb; 85(2):381-6. PubMed ID: 25623694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Plea for the Use of Video-recorded Cystoscopy for Blinded Independent Central Review of Tumor Response in Open-label Non-muscle invasive Bladder Cancer Trials.
    Basile G; Pradere B; Bellmunt J; Rouprêt M; Kamat AM; Seisen T
    Eur Urol Oncol; 2023 Oct; 6(5):453-455. PubMed ID: 37604762
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of office based flexible and rigid cystoscopy on pain experience in female patients.
    Casteleijn NF; Vriesema JL; Stomps SP; van Balen OL; Cornel EB
    Investig Clin Urol; 2017 Jan; 58(1):48-53. PubMed ID: 28097268
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.
    Herr HW
    Eur Urol; 2015 Apr; 67(4):605-8. PubMed ID: 25041849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The practice of the first check cystoscopy following radiotherapy for the treatment of muscle-invasive (T3N0M0) bladder cancer: a UK national survey.
    Mohammed A; Hameed A; Shergill I; Barua J
    Int Urol Nephrol; 2011 Jun; 43(2):377-81. PubMed ID: 20563846
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thulium laser resection via a flexible cystoscope for recurrent non-muscle-invasive bladder cancer: initial clinical experience.
    Gao X; Ren S; Xu C; Sun Y
    BJU Int; 2008 Nov; 102(9):1115-8. PubMed ID: 18565172
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder.
    Lämmle M; Beer A; Settles M; Hannig C; Schwaibold H; Drews C
    AJR Am J Roentgenol; 2002 Jun; 178(6):1483-8. PubMed ID: 12034625
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bladder urothelial neoplasms in pediatric age: experience at three tertiary centers.
    Berrettini A; Castagnetti M; Salerno A; Nappo SG; Manzoni G; Rigamonti W; Caione P
    J Pediatr Urol; 2015 Feb; 11(1):26.e1-5. PubMed ID: 25305695
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
    Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
    Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.
    Elsen S; Lerut E; Van Cleynenbreugel B; van der Aa F; van Poppel H; de Witte PA
    BJU Int; 2015 Sep; 116(3):468-77. PubMed ID: 25754262
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Aftercare of non-muscle invasive bladder cancer].
    Schulz GB; Schlenker B; Stief CG
    Urologe A; 2019 Aug; 58(8):943-952. PubMed ID: 31175377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.